Afficher la notice abrégée

dc.contributor.authorSinet, Mfr_FR
dc.contributor.authorKubar, Jfr_FR
dc.contributor.authorCondom, Rfr_FR
dc.contributor.authorPatino, Nfr_FR
dc.contributor.authorGuedj, Rfr_FR
dc.date.accessioned2013-02-18T16:17:14Z
dc.date.available2013-02-18T16:17:14Z
dc.date.issued1993fr_FR
dc.identifier.citationSinet, M ; Kubar, J ; Condom, R ; Patino, N ; Guedj, R, La protéine Tat du VIH : cible potentielle en chimiothérapie anti-rétrovirale, Med Sci (Paris), 1993, Vol. 9, N° 12; p.1342-51.fr_FR
dc.identifier.issn1958-5381fr_FR
dc.identifier.urihttp://hdl.handle.net/10608/2862
dc.description.abstractThe human immunodeficiency virus (HIV) encodes numerous regulatory proteins among which Tat and Rev are essential for virus replication. These proteins control HIV gene expression through interaction with specific regions of the viral RNA. The central role of the Tat protein in transforming HIV from a latent to an infective state makes it an attractive target for antiviral chemotherapy. This review summarizes the current knowledge on the structure and molecular characterization of Tat as well as its pivotal role in virus replication and its contribution to virus pathogenesis. The strategies which have already been applied and possible future approaches to identify the specific inhibitors of the function of this critical viral protein are described.fr
dc.language.isofrfr_FR
dc.publisherJohn Libbey Eurotext, Montrougefr_FR
dc.rightsArticle en libre accèsfr
dc.rightsMédecine/Sciences - Inserm - SRMSfr
dc.sourceM/S. Médecine sciences [revue papier, ISSN : 0767-0974], 1993, Vol. 9, N° 12; p.1342-51.fr_FR
dc.titleLa protéine Tat du VIH : cible potentielle en chimiothérapie anti-rétroviralefr
dc.typeArticlefr_FR
dc.identifier.doi10.4267/10608/2862


Fichier(s) constituant ce document

Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée